Ravgen
title: "Ravgen" type: doc version: 1 created: 2026-02-28 author: "Wikipedia contributors" status: active scope: public tags: ["biotechnology-companies-of-the-united-states"] topic_path: "geography/united-states" source: "https://en.wikipedia.org/wiki/Ravgen" license: "CC BY-SA 4.0" wikipedia_page_id: 0 wikipedia_revision_id: 0
Ravgen Inc. is a privately owned biotech company founded in 2000 by Chairman and C.E.O. Dr. Ravinder Dhallan. Ravgen Inc. performs research in the prenatal diagnostic field and has developed non-invasive prenatal diagnosis testing for Down Syndrome.
Publications and research
Ravgen has published peer-reviewed articles on genetic research in publications such as the Journal of the American Medical Association in 2004, The Lancet in 2007, and the New England Journal of Medicine in 2012. In addition, Ravgen has received some acclaim from its research on non-invasive prenatal DNA testing.
References
References
- (2018). "Solving the nonlinear Camassa Holm equation using quartic trigonometric B-spline collocation method". Author(s).
- Humphries, Courtney. (February 2, 2007). "A Simpler Test for Detecting Down's Syndrome | MIT Technology Review". Technologyreview.com.
- (2004). "Methods to Increase the Percentage of Free Fetal DNA Recovered from the Maternal Circulation". The Journal of the American Medical Association.
- (2007). "A noninvasive test for prenatal diagnosis based on fetal DNA present in maternal blood: a preliminary study". The Lancet.
- (2012). "A Noninasive Test to Determine Paternity in Pregnancy". The New England Journal of Medicine.
- (February 2, 2007). "Health | Hope for safe prenatal gene test". BBC News.
::callout[type=info title="Wikipedia Source"] This article was imported from Wikipedia and is available under the Creative Commons Attribution-ShareAlike 4.0 License. Content has been adapted to SurfDoc format. Original contributors can be found on the article history page. ::